ATE398116T1 - Benzothiophenderivate enthaltende antidiabetische verbindungen - Google Patents
Benzothiophenderivate enthaltende antidiabetische verbindungenInfo
- Publication number
- ATE398116T1 ATE398116T1 AT04790858T AT04790858T ATE398116T1 AT E398116 T1 ATE398116 T1 AT E398116T1 AT 04790858 T AT04790858 T AT 04790858T AT 04790858 T AT04790858 T AT 04790858T AT E398116 T1 ATE398116 T1 AT E398116T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds containing
- antidiabetic compounds
- benzothiophene derivatives
- containing benzothiophene
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0313612A FR2862645B1 (fr) | 2003-11-20 | 2003-11-20 | Composes antidiabetiques contenant des derives benzofuranes, benzothiophenes |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE398116T1 true ATE398116T1 (de) | 2008-07-15 |
Family
ID=34531150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04790858T ATE398116T1 (de) | 2003-11-20 | 2004-10-26 | Benzothiophenderivate enthaltende antidiabetische verbindungen |
Country Status (15)
Country | Link |
---|---|
US (1) | US7375130B2 (de) |
EP (1) | EP1685121B1 (de) |
JP (1) | JP4786545B2 (de) |
KR (1) | KR20060101491A (de) |
CN (1) | CN1882563A (de) |
AR (1) | AR046644A1 (de) |
AT (1) | ATE398116T1 (de) |
AU (1) | AU2004295029B2 (de) |
BR (1) | BRPI0416675A (de) |
CA (1) | CA2546647C (de) |
DE (1) | DE602004014401D1 (de) |
ES (1) | ES2308263T3 (de) |
FR (1) | FR2862645B1 (de) |
WO (1) | WO2005054225A1 (de) |
ZA (1) | ZA200605023B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2862646B1 (fr) * | 2003-11-20 | 2006-02-24 | Merck Sante Sas | Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes |
GB0506133D0 (en) * | 2005-03-24 | 2005-05-04 | Sterix Ltd | Compound |
AU2011202542A1 (en) | 2010-07-14 | 2012-02-02 | Indian Institute Of Science | Benzothiophene carboxamide compounds, composition and applications thereof |
CN104870429B (zh) * | 2013-05-22 | 2017-05-03 | 四川海思科制药有限公司 | 苯并呋喃衍生物、其制备方法及其在医药上的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3592907A (en) * | 1968-03-06 | 1971-07-13 | Dow Chemical Co | Substituted benzo(b)thiophene compositions |
US3989718A (en) * | 1975-05-06 | 1976-11-02 | Eli Lilly And Company | [1]Benzothieno[3,2-b]furans |
ZA858748B (en) * | 1984-12-10 | 1987-06-24 | Warner Lambert Co | Novel benzothiophenes and benzofurans having antiallergy activity |
IE64995B1 (en) * | 1987-07-14 | 1995-09-20 | Warner Lambert Co | Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome |
WO1995005170A1 (en) * | 1993-08-13 | 1995-02-23 | Warner-Lambert Company | Methods of inhibiting hiv and inhibiting the activation of hiv |
US5350748A (en) * | 1993-08-18 | 1994-09-27 | Warner-Lambert Company | 3-thio or amino substituted-benzo[b]thiophene-2-carboxamides and 3-oxygen, thio, or amino substituted-benzofuran-2-carboxamides as inhibitors of cell adhesion |
US5908859A (en) * | 1997-08-11 | 1999-06-01 | Eli Lilly And Company | Benzothiophenes for inhibiting hyperlipidemia |
EA200001175A1 (ru) * | 1998-05-12 | 2001-06-25 | Американ Хоум Продактс Корпорейшн | Бензотиофены, бензофураны и индолы, полезные в лечении устойчивости к инсулину и гипергликемии |
AU3791799A (en) * | 1998-05-12 | 1999-11-29 | American Home Products Corporation | Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
US6436965B1 (en) * | 2000-03-02 | 2002-08-20 | Merck Frosst Canada & Co. | PDE IV inhibiting amides, compositions and methods of treatment |
US20040259926A1 (en) * | 2003-06-05 | 2004-12-23 | Bruendl Michelle M. | 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents |
FR2862646B1 (fr) * | 2003-11-20 | 2006-02-24 | Merck Sante Sas | Nouveaux composes antidiabetiques contenant des derives benzofuranes, benzothiophenes |
-
2003
- 2003-11-20 FR FR0313612A patent/FR2862645B1/fr not_active Expired - Fee Related
-
2004
- 2004-10-26 AT AT04790858T patent/ATE398116T1/de not_active IP Right Cessation
- 2004-10-26 KR KR1020067009679A patent/KR20060101491A/ko not_active Application Discontinuation
- 2004-10-26 CN CNA2004800342573A patent/CN1882563A/zh active Pending
- 2004-10-26 US US10/580,033 patent/US7375130B2/en not_active Expired - Fee Related
- 2004-10-26 CA CA2546647A patent/CA2546647C/en not_active Expired - Fee Related
- 2004-10-26 AU AU2004295029A patent/AU2004295029B2/en not_active Ceased
- 2004-10-26 ES ES04790858T patent/ES2308263T3/es active Active
- 2004-10-26 WO PCT/EP2004/012075 patent/WO2005054225A1/en active IP Right Grant
- 2004-10-26 DE DE602004014401T patent/DE602004014401D1/de active Active
- 2004-10-26 EP EP04790858A patent/EP1685121B1/de active Active
- 2004-10-26 BR BRPI0416675-2A patent/BRPI0416675A/pt not_active Application Discontinuation
- 2004-10-26 JP JP2006540215A patent/JP4786545B2/ja not_active Expired - Fee Related
- 2004-11-19 AR ARP040104273A patent/AR046644A1/es unknown
-
2006
- 2006-06-19 ZA ZA200605023A patent/ZA200605023B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2546647C (en) | 2013-02-12 |
WO2005054225A1 (en) | 2005-06-16 |
US20070078178A1 (en) | 2007-04-05 |
FR2862645B1 (fr) | 2007-06-22 |
EP1685121B1 (de) | 2008-06-11 |
BRPI0416675A (pt) | 2007-02-13 |
AR046644A1 (es) | 2005-12-14 |
FR2862645A1 (fr) | 2005-05-27 |
EP1685121A1 (de) | 2006-08-02 |
JP2007511552A (ja) | 2007-05-10 |
CA2546647A1 (en) | 2005-06-16 |
KR20060101491A (ko) | 2006-09-25 |
US7375130B2 (en) | 2008-05-20 |
ES2308263T3 (es) | 2008-12-01 |
DE602004014401D1 (de) | 2008-07-24 |
ZA200605023B (en) | 2007-12-27 |
JP4786545B2 (ja) | 2011-10-05 |
AU2004295029A1 (en) | 2005-06-16 |
CN1882563A (zh) | 2006-12-20 |
AU2004295029B2 (en) | 2010-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE549329T1 (de) | Chinazoline verbindungen | |
IS7657A (is) | thíófen efnasambönd | |
IS8513A (is) | Lífræn efnasambönd | |
NO20055688D0 (no) | Organiske forbindelser | |
SE0302305D0 (sv) | Novel Compounds | |
DK1605897T3 (da) | Polyethelen-glycol-link-glp-1-forbindelser | |
IS8108A (is) | Ný efnasambönd | |
ATE404537T1 (de) | Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung | |
IL209082A0 (en) | Fushed heterocyclic compounds | |
IS8228A (is) | Ný asetídínefnasambönd | |
IS8089A (is) | Efnasambönd | |
IS8292A (is) | Ný efnasambönd | |
IS7833A (is) | Efnasambönd með sameinaða heteróhringi | |
DK1651034T3 (da) | Organiske forbindelser | |
NO20055097D0 (no) | Krystallinske N-formyl-hydroksylaminforbindelser | |
ATE398116T1 (de) | Benzothiophenderivate enthaltende antidiabetische verbindungen | |
NO20034952D0 (no) | Farmasöytiske forbindelser | |
NO20031736D0 (no) | Forbindelser | |
GB0300095D0 (en) | Organic compounds | |
NO20055170D0 (no) | Organiske forbindelser | |
SE0303452D0 (sv) | New compounds | |
ATE420079T1 (de) | Substituierte aralkyl verbindungen | |
SE0203608D0 (sv) | Thienyl compounds | |
SE0201187D0 (sv) | Thienyl compounds | |
SE0203606D0 (sv) | Heterocyclic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |